(Q52132151)

22 April 2018

title

Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer. (English)

1 reference

22 April 2018

1 reference

1 reference

Manyak MJ

1

1 reference

22 April 2018

Hinkle GH

2

1 reference

22 April 2018

Olsen JO

3

1 reference

22 April 2018

Chiaccherini RP

4

1 reference

22 April 2018

Partin AW

5

1 reference

22 April 2018

Piantadosi S

6

1 reference

22 April 2018

Burgers JK

7

1 reference

22 April 2018

Texter JH

8

1 reference

22 April 2018

Neal CE

9

1 reference

22 April 2018

Libertino JA

10

1 reference

22 April 2018

Wright GL Jr

11

1 reference

22 April 2018

Maguire RT

12

1 reference

22 April 2018

language of work or name

English

0 references

publication date

1 December 1999

1 reference

22 April 2018

published in

Urology

1 reference

22 April 2018

volume

54

1 reference

22 April 2018

issue

6

1 reference

22 April 2018

page(s)

1058-1063

1 reference

22 April 2018

Results of radical prostatectomy in men with clinically localized prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900314-3

7 January 2021

10.1016/S0090-4295(99)00314-3

Identifiers

DOI

1 reference

22 April 2018

1 reference

22 April 2018